ABBOTT PARK, Ill., June 9, 2017 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 374th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2017, to […]
Financial
Corindus Vascular Robotics Reports First Quarter 2017 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the quarter ended March 31, 2017. Recent Highlights and Accomplishments Realized revenue of $0.8 million in the first quarter 2017 Backlog of an additional $3.0 – $3.5 million in […]
Endologix Reports First Quarter 2017 Financial Results
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2017. “We are pleased with our progress during the quarter and our solid start to the year. Our top-line performance was driven by continued […]
Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (NASDAQ: CSII): Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third quarter ended March 31, 2017. The company’s third-quarter revenues were $52.1 […]
Bay Area’s Outset Medical Banks $76.5 Million for Innovative Dialysis Technology
SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the $13 billion global dialysis market, today announced $76.5 million in Series C equity funding. A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, which also included participation from existing investors Fidelity Management […]
Biomerics to Create 380+ New Jobs in $38.5 Million HQ Expansion
Biomerics Announces New Corporate Headquarters SALT LAKE CITY, Utah, May 1, 2017 /PRNewswire-USNewswire/ — Biomerics, a leading medical device manufacturer for the cardiovascular market, announced today it will relocate to a new corporate headquarters in Salt Lake City, UT. The 230,000 square foot facility will be located in the International […]
TransEnterix (TRXC) Announces Pricing Of $24.9 Million Public Offering Of Common Stock And Warrants
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT:TRXC) (“TransEnterix”), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced the pricing of its public offering of units, each consisting of one share of the Company’s common stock, one Series A warrant to purchase […]
Boston Scientific (BSX) Falls Short of Forecasts, Misses Q1 Earnings by a Penny
MARLBOROUGH, Mass., April 27, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.160 billion during the first quarter ended March 31, 2017. This represents growth of 10 percent compared to the prior year period on a reported and operational basis (calculated on a constant currency basis). The company reported […]
Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements
OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)– Lombard Medical, Inc. (EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (0853.HK), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have finalized the definitive agreements to their strategic partnership first […]
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
NEWS PROVIDED BY Codman Neuro | 10 Apr, 2017, 07:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Codman Neuro today announced the acquisition of Neuravi Limited, a privately held Irish company dedicated to advancing neurovascular therapies and improving clinical outcomes for acute ischemic stroke patients. This acquisition, and the recent […]